International Directory of Pharmaceutical Companies 2025: New Pharma Industry Directory Covers 200+ Countries, 20,000+ Companies & Key Executives
February 26, 2025 12:33 ET
|
Research and Markets
Dublin, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The "International Directory of Pharmaceutical Companies 2025" has been added to ResearchAndMarkets.com's offering. The International Directory of...
2025 Directory of Top 1,000 Pharmaceutical Companies: Business Profiles of Major International Pharma and Biotech Companies
February 26, 2025 11:49 ET
|
Research and Markets
Dublin, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The "Top 1000 Major Pharmaceutical Companies 2025" directory has been added to ResearchAndMarkets.com's offering. Essential for those doing business in...
USA Pharmaceutical Directory 2025: Access Details for Over 4,000 Pharmaceutical Companies and 8,000+ Executives Working in the Pharma Industry
February 25, 2025 11:01 ET
|
Research and Markets
Dublin, Feb. 25, 2025 (GLOBE NEWSWIRE) -- The "USA Pharmaceutical Directory 2025" has been added to ResearchAndMarkets.com's offering. The USA Pharmaceutical Directory is one of the most...
Pharma Supply Chain & Security Conference 2025: Focus on Optimizing your Challenges to Ensure an Agile, Responsive, Streamlined and Secured Supply Chain (London, United Kingdom - March 12-13, 2025)
February 20, 2025 05:29 ET
|
Research and Markets
Dublin, Feb. 20, 2025 (GLOBE NEWSWIRE) -- The "Pharma Supply Chain & Security World 2025" conference has been added to ResearchAndMarkets.com's offering. The Annual Pharma Supply Chain &...
LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
February 11, 2025 08:42 ET
|
Lixte Biotechnology Holdings, Inc.
PASADENA, CALIF., Feb. 11, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced...
Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones
February 04, 2025 09:25 ET
|
Jupiter Neurosciences, Inc.
Jupiter, Florida, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a patented...
Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
January 30, 2025 17:17 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, Md, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
KRTL Holding Group Inc. Announces Milestone Achievement: FDA Registration of Industria Químico Farmaceutica SIGMA CORP. S.R.L.’s Federal Establishment Identifier
January 22, 2025 09:00 ET
|
KRTL Holding Group
Lakewood, CO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- KRTL Holding Group Inc. proudly announces the successful registration of Industria Químico Farmaceutica SIGMA CORP. S.R.L. (SIGMA), a premier Bolivian...
KRTL Holding Group Inc. Announces KRTL Biotech Inc. Acquires 55% Majority Stake in Nutrivance Global to Enhance API Distribution and Real-World Data Capabilities
January 08, 2025 09:00 ET
|
KRTL Holding Group
Lakewood, CO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- KRTL Holding Group Inc. (OTC: KRTL) announces that its wholly owned subsidiary, KRTL Biotech Inc., has acquired a 55% majority equity stake in...
CMO in Pharmaceutical Industry Market Research 2024-2028: Lower Costs, High Compliance - Why Pharma Companies Are Outsourcing to Emerging Markets
January 02, 2025 05:33 ET
|
Research and Markets
Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "CMO in Pharmaceutical Industry Market 2024-2028" report has been added to ResearchAndMarkets.com's offering. The CMO in pharmaceutical industry...